Last updated: 12 September 2026 · Content curated by Dr. Shabnam Choudhary · Medically reviewed by Dr. Saffiyyah Chaudhary
Quick Answer
Autologous Stem Cell Transplant in India is typically planned at $18,000–$48,000. The stored stay is 3–5 weeks in or near the unit, but the actual episode depends on eligibility, the procedure-specific plan, complications and discharge criteria.
Stem cells are mobilised with medicines, collected by apheresis and frozen. After high-dose conditioning, the thawed cells are infused; blood counts then fall before engraftment. mobilisation and collection take days, followed by conditioning, infusion and commonly two to three weeks to initial count recovery. A written estimate should use the exact procedure name and state its clinical assumptions.
- India cost range
- $18,000–$48,000
- Typical starting point
- $18,000
- Typical hospital stay
- 3–5 weeks in or near the unit
- Procedure time
- mobilisation and collection take days, followed by conditioning, infusion and commonly two to three weeks to initial count recovery
- Recovery
- Fatigue, appetite and immune recovery continue after engraftment; blood counts, infection risk and organ effects determine discharge rather than a fixed package day.
Major cost factors: mobilisation and collection yield, conditioning regimen, cryopreservation and cell processing, neutropenic ward and engraftment time. International patients should also budget for accommodation, airport transfers, a medical visa, medicines and follow-up.
Often quoted separately: failed or repeat mobilisation; disease therapy before transplant; critical care and major infection treatment; extended cryostorage; later maintenance and revaccination.
Why request a cost through GAF rather than a hospital?
Writing to one campus gets you that campus’s package. A GAF request is reviewed against your records and returned as suitable doctor and hospital options with an indicative, itemised estimate. There is no obligation to book.
- Doctor review first. The number follows a reading of your imaging, test results and clinical records, not a brochure range.
- Hospital options. You can compare listed campuses before you travel, instead of starting over with each international desk.
- International-patient coordination. Visa letters, records routing and companion logistics sit with the same request.
An autologous stem cell transplant collects and cryopreserves the patient's own blood-forming stem cells, gives high-dose chemotherapy, then returns those cells to restore marrow production. It may consolidate response in selected myeloma or lymphoma pathways and is also used for certain other protocol-defined diseases when disease control and organ fitness are adequate.
Review includes diagnosis and response imaging, prior regimens, marrow reserve, cardiac, lung, kidney and liver assessment, infection screening, dental review where required and an apheresis collection plan. It is not suitable merely because cells can be collected. Progressive disease, inadequate collection, active infection or organ dysfunction may require delay, another strategy or care near home.
Stem cells are mobilised with medicines, collected by apheresis and frozen. After high-dose conditioning, the thawed cells are infused; blood counts then fall before engraftment. Collection is usually outpatient, while conditioning and the neutropenic period may be inpatient or closely supervised ambulatory care with immediate admission access.
The catalog stores $18,000–$48,000 for India, $140,000–$320,000 for typical US self-pay and 3–5 weeks in or near the unit for broad travel planning. These are comparison tokens, not medical acceptance, an outcome forecast or a hospital quotation.
What Is Autologous Stem Cell Transplant?
An autologous stem cell transplant collects and cryopreserves the patient's own blood-forming stem cells, gives high-dose chemotherapy, then returns those cells to restore marrow production.
Stem cells are mobilised with medicines, collected by apheresis and frozen. After high-dose conditioning, the thawed cells are infused; blood counts then fall before engraftment.
It is not suitable merely because cells can be collected. Progressive disease, inadequate collection, active infection or organ dysfunction may require delay, another strategy or care near home.
When Is Autologous Stem Cell Transplant Considered?
It may consolidate response in selected myeloma or lymphoma pathways and is also used for certain other protocol-defined diseases when disease control and organ fitness are adequate.
Review includes diagnosis and response imaging, prior regimens, marrow reserve, cardiac, lung, kidney and liver assessment, infection screening, dental review where required and an apheresis collection plan.
How treatment is given, monitored and adapted →
Autologous Stem Cell Transplant cost in India
The $18,000–$48,000 value is the stored national planning range for autologous stem cell transplant. It may cover only the items expressly named in a hospital letter and does not establish a tariff for any city or provider.
Important drivers include mobilisation and collection yield, conditioning regimen, cryopreservation and cell processing, neutropenic ward and engraftment time, infection, transfusion or icu support. A changed donor, graft, conditioning plan, laboratory work-up or complication can describe a materially different episode.
Do not divide the national range into invented city prices. Compare itemized estimates after record review, and budget travel, caregiver lodging and care after return separately.
Collection is usually outpatient, while conditioning and the neutropenic period may be inpatient or closely supervised ambulatory care with immediate admission access. Long-haul travel waits for count recovery, clinical stability and explicit clearance. The patient should not book departure for the day neutrophils first rise.
Autologous Stem Cell Transplant cost breakdown in India
Component prices are rarely published as a public tariff. The lines below describe what typically sits inside a treatment estimate, not a dollar amount for each row.
- Transplant eligibility assessment
- Disease response, organ function and infection review as stated.
- Mobilisation and quoted apheresis sessions
- Named medicines and collection-day allowance.
- Cell processing and cryopreservation
- Testing, freezing and storage period only when written.
- Conditioning and stem-cell infusion
- The named regimen, pharmacy and infusion episode.
- Quoted transplant stay and monitoring
- Blood counts, stated blood products and routine supportive care within defined limits.
Planning range or quotation?
The $18,000–$48,000 figure is an indicative planning range. A final hospital quotation is itemised, issued after a consultant reviews your records, and still subject to what is found clinically.
Get a Personalized Cost Estimate
What is usually included in a Autologous Stem Cell Transplant package?
No two hospitals draw the line in the same place, so read an estimate for what it excludes as carefully as for what it covers. The pattern below is what listed campuses typically bundle into a hematology estimate for this treatment. Anything not written into your estimate should be assumed to be extra until the hospital confirms otherwise.
Usually included
Usually included
Transplant eligibility assessment
Disease response, organ function and infection review as stated.
Usually included
Mobilisation and quoted apheresis sessions
Named medicines and collection-day allowance.
Usually included
Cell processing and cryopreservation
Testing, freezing and storage period only when written.
Usually included
Conditioning and stem-cell infusion
The named regimen, pharmacy and infusion episode.
Usually included
Quoted transplant stay and monitoring
Blood counts, stated blood products and routine supportive care within defined limits.
May be charged separately
May be separate
Failed or repeat mobilisation
Additional medicines and collection days unless expressly included.
May be separate
Disease therapy before transplant
Salvage or bridging treatment needed to reach response.
May be separate
Critical care and major infection treatment
ICU, prolonged antimicrobials or organ support outside the allowance.
May be separate
Extended cryostorage
Storage beyond the quoted interval and disposal arrangements.
May be separate
Later maintenance and revaccination
Post-transplant medicines, vaccines and surveillance after the included visits.
Catalog inclusions listed for this pathway: haematology consultation and records review; named consultant on camera before travel; donor search or collection plan as quoted; inpatient transplant or day-care procedure as indicated; discharge summary to your home haematologist.
What can increase the cost?
These are the drivers that actually move a bill for this procedure, in rough order of how often they do it. Most of them are clinical decisions rather than commercial ones, which is why an honest estimate is written after a records review rather than before it.
- Mobilisation and collection yield
- Extra apheresis days or rescue mobilisation changes the episode.
- Conditioning regimen
- Diagnosis-specific high-dose therapy changes medicines and monitoring.
- Cryopreservation and cell processing
- Collection, testing, freezing and storage must be itemized.
- Neutropenic ward and engraftment time
- Delayed count recovery adds nights and supportive care.
- Infection, transfusion or ICU support
- Complications are not predictable package add-ons.
Clinical pathways related to Autologous Stem Cell Transplant
It is not suitable merely because cells can be collected. Progressive disease, inadequate collection, active infection or organ dysfunction may require delay, another strategy or care near home. The alternatives below are selected clinically, not as price upgrades.
A Transplant hematologist should explain why the proposed pathway fits the diagnosis and what finding could change it.
Swipe to compare treatment approaches →
| Approach | Relative complexity | GAF planning range | Notes |
|---|---|---|---|
| Peripheral-blood autograft | Selected from diagnosis, fitness and laboratory findings | No separate GAF sheetRelative complexity only | The usual graft source after successful mobilisation and apheresis. |
| Additional mobilisation or plerixafor | Selected from diagnosis, fitness and laboratory findings | No separate GAF sheetRelative complexity only | Considered when predicted or actual stem-cell yield is inadequate. |
| Non-transplant consolidation | Selected from diagnosis, fitness and laboratory findings | No separate GAF sheetRelative complexity only | A clinical alternative when disease response, collection or fitness does not support high-dose therapy. |
Planning ranges appear only where GAF Healthcare already publishes a cost sheet for that procedure. Other rows describe relative clinical complexity and should not be read as prices.
Risks and safety considerations for Autologous Stem Cell Transplant
Important risks include severe infection during neutropenia, mucositis, nausea, diarrhoea, bleeding, organ toxicity, infertility and failure or delay of count recovery. Autologous grafts do not cause graft-versus-host disease.
This is not an exhaustive consent list and does not assign likelihood. Individual risks depend on diagnosis, current blood counts, comorbidity and the actual protocol.
A Transplant hematologist must discuss alternatives, uncertainty and the signs that need urgent assessment; no page can promise success or an uncomplicated recovery.
Autologous Stem Cell Transplant cost: India vs other medical tourism destinations
India and United States values use stored GAF ranges. Other country rows are modelled relative private-care bands, not official tariffs or proof that a centre will accept the case.
International comparisons are unreliable unless diagnosis, donor or specimen work, protocol, ward scope, medicines and complication coverage match.
Swipe to compare destinations →
| Country | Approximate cost | Relative cost position | Important cost considerations |
|---|---|---|---|
| India | $18,000–$48,000 | Baseline | GAF catalog planning range. The stored India value is a planning band. A named Hematology specialist must review diagnosis, disease status, donor or graft details and organ fitness before a case-specific quotation. |
| Turkey | $36,500–$59,500Indicative planning estimate* | ≈1.4× India | Private international-care market. Confirm donor work, graft procurement, laboratory testing, ward isolation, complications and outpatient monitoring rather than comparing a headline package. |
| Thailand | $43,000–$72,500Indicative planning estimate* | ≈1.8× India | Private international hospitals. International-patient support does not establish transplant eligibility, donor availability, laboratory scope or a safe handover after return. |
| United Arab Emirates | $72,500–$119,000Indicative planning estimate* | ≈2.9× India | Regional premium private care. Travel may be shorter for some families, while professional fees, graft services, medicines and complication care may remain separate. |
| Singapore | $92,500–$158,500Indicative planning estimate* | ≈3.8× India | High-cost specialist private care. Request an international self-pay estimate tied to the diagnosis, protocol and donor or specimen work rather than a general haematology package. |
| Germany | $82,500–$148,500Indicative planning estimate* | ≈3.5× India | European elective specialist care. Eligibility, donor-registry access, professional billing and post-treatment arrangements vary and must be established before travel. |
| United Kingdom | $72,500–$132,000Indicative planning estimate* | ≈3.1× India | Private self-pay for many visitors. Overseas patients should verify acceptance, donor or laboratory access, quote boundaries and who provides follow-up after discharge. |
| United States | $140,000–$320,000 | ≈7× India | Stored self-pay reference. Hospital, specialist, donor, laboratory and pharmacy charges may be billed separately; $140,000–$320,000 is a comparison range, not one bundled quotation. |
*Figures other than India and the United States are modelled planning estimates scaled from the India catalog band, not hospital quotations. All values are planning information. Disease status, donor or graft source, testing, medicines, complications, currency and length of stay can change the final amount; no row predicts safety or outcome.
The point of this table is not that one country is better. Cost level and treatment-market structure are different things. Compare the named hospital, multidisciplinary support, included care and follow-up pathway as carefully as the headline figure.
Which destination is right for you?
Use this only as a reading guide for the table above. It is not a medical recommendation, and it does not rank countries.
Looking for the lowest overall treatment cost?
IndiaLooking for premium private hospital infrastructure?
Singapore / UAELooking for proximity from the Middle East?
UAE / India / TurkeyLooking for established European oncology systems?
Germany / UK
Why do international patients consider India for autologous stem cell transplant?
Some international patients compare India for access to a named Transplant hematologist and a self-pay planning range below typical United States figures. Price alone is not a reason to travel.
Clinical acceptance, exact quote scope, emergency capacity, caregiver logistics and continuity after return need direct confirmation.
Urgent illness, uncontrolled infection, lack of a safe caregiver plan or funded appropriate care near home may make international travel unsuitable.
Hematology hospitals for autologous stem cell transplant in India
Hospital cards should follow live entity relationships. A general oncology or accreditation label does not establish current transplant beds, apheresis, donor access, haematopathology scope, ICU support or outcomes.
Indraprastha Apollo Hospital
JCI Accredited
NABH Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Hindi
Apollo Hospital, Jubilee Hills, Hyderabad
- JCI Accredited
- NABH Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Telugu, Hindi
Artemis Hospital
- JCI Accredited
- NABH Accredited
- DHADHA
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Hindi
BLK-Max Super Speciality Hospital
- JCI Accredited
- NABH Accredited
NABL Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Hindi
Fortis Hospital, Noida
- JCI Accredited
- NABH Accredited
- NABL Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Hindi
Fortis Hospital, Shalimar Bagh
- JCI Accredited
- NABH Accredited
- NABL Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Hindi
Gleneagles Hospitals, Bengaluru
- JCI Accredited
- NABH Accredited
- NABL Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
1 listed doctor for this pathway
Languages listed: English, Kannada, Hindi
Medanta - The Medicity
- JCI Accredited
- NABH Accredited
- NABL Accredited
- Radiation Oncology
- Surgical Oncology
- Medical Oncology
- Hematology
2 listed doctors for this pathway
Languages listed: English, Hindi
Autologous Stem Cell Transplant hospitals in India · Talk to a treatment coordinator
Transplant hematologists for autologous stem cell transplant in India
Profiles must be drawn dynamically only when Autologous Stem Cell Transplant appears in current procedure relationships. Verify the clinician's Hematology role, responsibility for this pathway, availability and campus. Placement is not a ranking or an experience or outcome claim.
Dr. Ajay Gupta
Hematology
17+ years Experience
Bone Marrow Transplant (BMT) · Autologous Stem Cell Transplant (ASCT) · Haploidentical Bone Marrow Transplant
English, Hindi
Dr. Akshay Shah
Hematology
22+ years Experience
Acute Leukemia · Autologous Stem Cell Transplant (ASCT) · Blood Cancer Treatment (Leukemia, Lymphom…
English, Hindi, Marathi
Dr. G. Vikram Kumar
Hematology
18+ years Experience
Bone Marrow Transplant (BMT) · Haploidentical Bone Marrow Transplant · Autologous Stem Cell Transplant (ASCT)
English, Telugu, Hindi
Dr. Govind Eriat
Hematology
14+ years Experience
Bone Marrow Transplant (BMT) · Autologous Stem Cell Transplant (ASCT) · Haploidentical Bone Marrow Transplant
English, Kannada, Hindi
Dr. M. Gopinathan
Hematology
13+ years Experience
Bone Marrow Transplant (BMT) · Autologous Stem Cell Transplant (ASCT) · Blood Cancer Treatment (Leukemia, Lymphom…
English, Tamil, Hindi
Dr. Divya Doval
Hematology
11+ years Experience
Allogeneic Bone Marrow Transplant · Autologous Bone Marrow Transplant · Bone Marrow Transplant
English, Hindi
Dr. Muralidaran C
Hematology
9+ years Experience
Bone Marrow Transplant (BMT) · Autologous Stem Cell Transplant (ASCT) · Haploidentical Bone Marrow Transplant
English, Hindi, Marathi
Dr. K. Karuna Kumar
Hematology
18+ years Experience
Bone Marrow Transplant (BMT) · Autologous Stem Cell Transplant (ASCT) · Haploidentical Bone Marrow Transplant
English, Telugu, Hindi
Autologous Stem Cell Transplant doctors in India (17 listed) · Get a personalized cost estimate
Autologous Stem Cell Transplant cost by city in India
Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad use $18,000–$48,000 because no verified city tariffs are stored. Their overlays address different airport, commute, climate and caregiver logistics without inventing local prices.
Specialist and hospital cards must resolve from current procedure relationships. This article names no provider and makes no ranking, volume, accreditation or outcome claim.
Swipe to compare Indian cities →
Delhi NCR
$18,000–$48,000
India planning band — not a city quote
Typical stay 3–5 weeks in or near the unit
No verified Delhi NCR-only tariff is stored for autologous stem cell transplant. Use $18,000–$48,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
7 hospitals · 8 doctors
Mumbai
$18,000–$48,000
India planning band — not a city quote
Typical stay 3–5 weeks in or near the unit
No verified Mumbai-only tariff is stored for autologous stem cell transplant. Use $18,000–$48,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
2 hospitals · 2 doctors
Bengaluru
$18,000–$48,000
India planning band — not a city quote
Typical stay 3–5 weeks in or near the unit
No verified Bengaluru-only tariff is stored for autologous stem cell transplant. Use $18,000–$48,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
1 hospital · 1 doctor
Chennai
$18,000–$48,000
India planning band — not a city quote
Typical stay 3–5 weeks in or near the unit
No verified Chennai-only tariff is stored for autologous stem cell transplant. Use $18,000–$48,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
1 hospital · 1 doctor
Hyderabad
$18,000–$48,000
India planning band — not a city quote
Typical stay 3–5 weeks in or near the unit
No verified Hyderabad-only tariff is stored for autologous stem cell transplant. Use $18,000–$48,000 as a national planning range until a named hospital issues an itemized estimate; it is not a guaranteed package.
4 hospitals · 5 doctors
Costs vary considerably by hospital, specialist, clinical complexity, insurance, room or day-care category, and what is included in the package.
Choosing a city for autologous stem cell transplant
Patients usually pick the treating team first and the city second. The city still affects daily travel, accommodation, companion arrangements and access to follow-up. Here is what genuinely differs between the five cities we list.
What should international patients budget beyond the hematology procedure or treatment?
A complete autologous stem cell transplant budget extends beyond $18,000–$48,000. Include record review, tests outside the letter, companion travel, lodging, medicines, complication contingency and follow-up at home.
Travel should follow written clinical acceptance. A visa invitation or directory profile is not medical clearance.
- Eligibility and response review
- Confirm disease indication, response, organ fitness and infection status.
- Mobilisation
- Growth factor with or without chemotherapy and plerixafor according to collection risk.
- Apheresis and freezing
- Collect until the protocol target is met, test and cryopreserve the autograft.
- Conditioning and infusion
- Give high-dose therapy, then reinfuse the patient's thawed cells.
- Aplasia and engraftment
- Provide infection precautions, transfusions and symptom support while counts recover.
- Discharge and handover
- Confirm stability, medicines, emergency thresholds, vaccination and disease follow-up.
- Treatment episode$18,000–$48,000
- Pre-operative testsOften inside the estimate — confirm
- Hospital stay3–5 weeks in or near the unit typically bundled
- Additional procedures or extended careQuoted separately if advised
- Accommodation for companionVaries by city and length of stay
- Local transportationAirport and daily hospital transfers
- FlightsDepends on origin
- Medical visaFee set by the issuing consulate
Planning estimate — not a hospital quotation.
Get a Personalized Treatment Estimate
What does medical travel for autologous stem cell transplant in India involve?
The sequence below is how a records-first pathway normally runs. The order matters: everything before arrival exists so that you are not making decisions in an unfamiliar hospital corridor with a suitcase beside you.
Send complete records
Complete pathology and disease-response imaging; All prior regimens and toxicities; Recent marrow and blood counts; Organ-function and infection-screen results; Any previous stem-cell collection report.
Obtain specialist acceptance
A named Transplant hematologist confirms whether the proposed procedure and travel are reasonable from the available evidence.
Clarify alternatives and uncertainty
It is not suitable merely because cells can be collected. Progressive disease, inadequate collection, active infection or organ dysfunction may require delay, another strategy or care near home. Ask what new result could change or cancel the plan.
Compare itemized estimates
Use the same clinical assumptions and compare laboratory, pharmacy, ward, professional and complication terms.
Plan flexible travel
Arrange documents, a capable caregiver when required, refundable travel and accommodation close to the exact campus.
Repeat assessment after arrival
Review includes diagnosis and response imaging, prior regimens, marrow reserve, cardiac, lung, kidney and liver assessment, infection screening, dental review where required and an apheresis collection plan.
Complete the planned procedure
Stem cells are mobilised with medicines, collected by apheresis and frozen. After high-dose conditioning, the thawed cells are infused; blood counts then fall before engraftment.
Monitor recovery
Fatigue, appetite and immune recovery continue after engraftment; blood counts, infection risk and organ effects determine discharge rather than a fixed package day. fever, rigors, uncontrolled diarrhoea or vomiting, bleeding, chest pain, breathlessness or new confusion require prompt review.
Receive discharge records
Carry the procedure summary, laboratory or pathology results, medicine list, emergency contacts and follow-up schedule.
Continue care at home
The transplant team monitors counts, infection, medicines and disease response, then hands care to a local hematologist with vaccination and survivorship plans.
Documents to prepare
- Complete pathology and disease-response imaging
- All prior regimens and toxicities
- Recent marrow and blood counts
- Organ-function and infection-screen results
- Any previous stem-cell collection report
Clinical detail
How the treatment is delivered
Stem cells are mobilised with medicines, collected by apheresis and frozen. After high-dose conditioning, the thawed cells are infused; blood counts then fall before engraftment.
Related approaches include Peripheral-blood autograft, Additional mobilisation or plerixafor, Non-transplant consolidation; they are not interchangeable package labels.
Collection is usually outpatient, while conditioning and the neutropenic period may be inpatient or closely supervised ambulatory care with immediate admission access. mobilisation and collection take days, followed by conditioning, infusion and commonly two to three weeks to initial count recovery.
Main variations
- Peripheral-blood autograft
- The usual graft source after successful mobilisation and apheresis.
- Additional mobilisation or plerixafor
- Considered when predicted or actual stem-cell yield is inadequate.
- Non-transplant consolidation
- A clinical alternative when disease response, collection or fitness does not support high-dose therapy.
Preparation
Review includes diagnosis and response imaging, prior regimens, marrow reserve, cardiac, lung, kidney and liver assessment, infection screening, dental review where required and an apheresis collection plan.
The receiving Transplant hematologist should review the complete files, reconcile medicines and explain consent, alternatives and what could postpone or cancel the procedure.
Report fever, active infection, new bleeding, breathing difficulty or a material change in condition promptly; urgent local care should not be delayed for travel.
Hospital stay and recovery
Fatigue, appetite and immune recovery continue after engraftment; blood counts, infection risk and organ effects determine discharge rather than a fixed package day. The transplant team monitors counts, infection, medicines and disease response, then hands care to a local hematologist with vaccination and survivorship plans.
The catalog stay of 3–5 weeks in or near the unit is a planning aid, not a discharge promise. Long-haul travel waits for count recovery, clinical stability and explicit clearance. The patient should not book departure for the day neutrophils first rise.
Important risks include severe infection during neutropenia, mucositis, nausea, diarrhoea, bleeding, organ toxicity, infertility and failure or delay of count recovery. Autologous grafts do not cause graft-versus-host disease.
Seek urgent clinical help for fever, rigors, uncontrolled diarrhoea or vomiting, bleeding, chest pain, breathlessness or new confusion. Follow the treating team's own emergency thresholds.
How to compare Autologous Stem Cell Transplant quotes from Indian hospitals
Print these and work through them on the video call. A house that answers without hedging is telling you something useful about how it will behave when something goes wrong.
- Why is autologous stem cell transplant being considered now, and what alternatives were discussed?
- Which diagnosis, pathology or laboratory result drives the recommendation?
- Who is the named Transplant hematologist responsible for the plan?
- At which exact campus will each stage occur?
- What could postpone, change or cancel the procedure after arrival?
- Does the quotation use the exact procedure name and clinical assumptions?
- Which consultations, laboratory tests and imaging are included?
- Which medicines, blood products and supportive care are included?
- How many day-care visits or ward nights are allowed?
- How are intensive care, infection, bleeding and an extended stay billed?
- Which professional, laboratory, pharmacy or donor charges are separate?
- What caregiver presence and nearby accommodation are required?
- What emergency symptoms require return to the unit?
- Who provides care if the patient becomes unwell after returning home?
- When is fitness to fly assessed, and must return travel remain flexible?
- Which mobilisation medicines and how many apheresis days are included?
- What CD34 collection target is planned and what happens if it is not reached?
- How long is cryostorage included?
- Which conditioning regimen is priced?
- Which transfusions and antimicrobial prophylaxis are included?
- What count and clinical criteria govern discharge?
Frequently asked questions
How much does autologous stem cell transplant cost in India?
Autologous Stem Cell Transplant is typically planned at $18,000–$48,000. This stored range is not a quote; eligibility, the exact pathway and hospital terms determine the final amount.
What is autologous stem cell transplant?
An autologous stem cell transplant collects and cryopreserves the patient's own blood-forming stem cells, gives high-dose chemotherapy, then returns those cells to restore marrow production.
When is autologous stem cell transplant considered?
It may consolidate response in selected myeloma or lymphoma pathways and is also used for certain other protocol-defined diseases when disease control and organ fitness are adequate.
Who may not be ready for this procedure?
It is not suitable merely because cells can be collected. Progressive disease, inadequate collection, active infection or organ dysfunction may require delay, another strategy or care near home.
What records are needed before acceptance?
Review includes diagnosis and response imaging, prior regimens, marrow reserve, cardiac, lung, kidney and liver assessment, infection screening, dental review where required and an apheresis collection plan.
What happens during the procedure?
Stem cells are mobilised with medicines, collected by apheresis and frozen. After high-dose conditioning, the thawed cells are infused; blood counts then fall before engraftment.
How long does autologous stem cell transplant take?
mobilisation and collection take days, followed by conditioning, infusion and commonly two to three weeks to initial count recovery. The stored 3–5 weeks in or near the unit is only a travel-planning guide.
Is admission required?
Collection is usually outpatient, while conditioning and the neutropenic period may be inpatient or closely supervised ambulatory care with immediate admission access.
What are the important risks?
Important risks include severe infection during neutropenia, mucositis, nausea, diarrhoea, bleeding, organ toxicity, infertility and failure or delay of count recovery. Autologous grafts do not cause graft-versus-host disease.
What can change the hospital estimate?
Key drivers include mobilisation and collection yield, conditioning regimen, cryopreservation and cell processing, neutropenic ward and engraftment time, infection, transfusion or icu support.
When can an international patient fly home?
Long-haul travel waits for count recovery, clinical stability and explicit clearance. The patient should not book departure for the day neutrophils first rise.
What follow-up is needed?
The transplant team monitors counts, infection, medicines and disease response, then hands care to a local hematologist with vaccination and survivorship plans.
Dr. Shabnam Choudhary, BDS, is a dental professional who graduated from Al-Ameen Medical College, Bijapur, Karnataka. She contributes to the curation and development of medically informative healthcare content, helping ensure that information is structured clearly and presented in a patient-friendly manner.
Content Curator
Dr. Shabnam Choudhary
BDS
Al-Ameen Medical College, Bijapur, Karnataka
Rajiv Gandhi University of Health Sciences (RGUHS), Bengaluru
Dr. Saffiyyah Chaudhary, BDS, is a dental professional who graduated from Al-Ameen Medical College, Bijapur, Karnataka. She provides medical review of healthcare content to help ensure that clinical information is accurate, understandable, and appropriately presented for patients and their families.
Medically Reviewed By
Dr. Saffiyyah Chaudhary
BDS
Al-Ameen Medical College, Bijapur, Karnataka
Rajiv Gandhi University of Health Sciences (RGUHS), Bengaluru
Related treatment costs
Stem Cell Transplantation cost in India
$22,000–$65,000 · stay Auto or allo · 3–8 weeks
Bone Marrow Transplantation cost in India
$25,000–$70,000 · stay 4–8 weeks in or near the unit
Bone Marrow Biopsy cost in India
$300–$900 · stay Day-care
Cost note
Cost ranges on this page are for preliminary planning and comparison only. The final treatment cost depends on the patient's diagnosis, treatment plan, hospital, doctor, procedure complexity and other clinical factors. A personalized quotation should be obtained before making treatment or travel decisions.
This page is general information about treatment costs and pathways. It is not a diagnosis, a treatment recommendation or a substitute for an individualised medical opinion. Decisions about whether this procedure is appropriate for you belong to a qualified doctor who has reviewed your records.
Last updated 12 September 2026. Cost data is maintained separately from this article and refreshed as listed campuses revise their planning ranges.
Autologous Stem Cell Transplant cost sheet · All treatment costs in India · Hematology costs
